Clinical trial
IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment)
NCT00268632 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00268632 |
|---|---|
| Title | IMPACT Study (Improving Measurements of Persistence on "ACtonel" Treatment) |
| Official title | A Multicenter Prospective Study to Assess the Impact of Physician's Reinforcement on the Subject's Compliance and Persistence on Treatment Using Feedback on Bone Markers in Previously Undiagnosed Postmenopausal Osteoporotic Women Treated With Risedronate. |
| Lead sponsor | Sanofi, Industry |
| Collaborators | Procter and Gamble Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | risedronate |
| Start date | Aug 1, 1999 |
| Primary completion | Feb 1, 2002 |
| First posted | Dec 22, 2005 |
| Last update posted | Jan 11, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: